Company / Total Debt
BeOne Medicines Ltd. Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$836.4M
FY2025
5-year range
$166.5M / $836.4M
FY2021-FY2025
Trend
+402.4%
vs FY2024
Sector context
#25 of 83
Health Care
What the data says
Total Debt changed +402% YoY in FY2025, a notable deviation from the 9-year average annual change of +102%.
Based on SEC 10-K filings.
$836M in FY2025 with a 5-year CAGR of +35.4%.
Increased from $198M to $836M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- +58.7%
- 5-Year CAGR
- +35.4%
- 10-Year CAGR
- -
Sector benchmark
#59 of 83 in Health CareTop 70% of 83This company $836.4M Sector average $6.2B
▼
-86.4% below sector average
Key checks
Key Insights
- 5-year CAGR of +35.4%, indicating consistent growth.
- In FY2025, total debt increased 402.4% year-over-year.
- Ranks #25 out of 83 companies in the Health Care sector.
- Lowest total debt in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $836.4M | +402.4% |
| FY2024 | $166.5M | -15.8% |
| FY2023 | $197.6M | -5.5% |
| FY2022 | $209.1M | +3.5% |
| FY2021 | $202.1M | +10.1% |
| FY2020 | $183.6M | +120.4% |
| FY2019 | $83.3M | +104.3% |
| FY2018 | $40.8M | +342.3% |
| FY2017 | $9.2M | -46.6% |
| FY2016 | $17.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026